Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic — Dharavi, Mumbai, India, 2020–2022
by from Morbidity and Mortality Weekly Report (MMWR) on (#6A3YV)
This report describes disruptions to continuity of care for people in Dharavi with drug-resistant tuberculosis.